REGULATORY · COMPETITIVE · INDIA
Delhi HC orders patent office to decide Ribociclib
Change
The Delhi High Court ordered the Controller General of Patents to decide Novartis's Ribociclib patent application and oppositions and to frame an SOP with timeline-bound disposal, within four months.
Why it matters
The Controller General must draft a standard operating procedure that sets disposal timelines for patent applications. The directive specifically covers the Novartis Ribociclib application and oppositions filed against it. The Controller is required to decide the application and oppositions within four months. Timely disposal of patent applications must be prioritized and timelines adhered to.
Implications
- · Patent-office leadership must implement and enforce a new SOP that assigns firm timelines for case disposal.
- · Examiners will face mandated prioritization and compressed scheduling to meet the four-month decision window for the Ribociclib matter.
- · Patent applicants and opposing parties will operate under shortened procedural timelines for submissions and responses.
- · Patent prosecution and litigation counsel must adjust case management to align with the court-ordered timetable.
Who is affected
- · Patent office examiners and leadership
- · Pharmaceutical patent applicants
- · Opposition parties to patent applications
- · Patent prosecution and litigation counsel
What to watch
- · Four-month deadline for decision on the Ribociclib patent application and oppositions
Source
Topics
Law & Public Safety Regulatory Actions Intellectual Property Health & Medicine Pharma & Biotech